Editor: Farrah Mateen, MD, PhD, FAAN

Farrah Mateen, MD, PhD

Farrah Mateen, MD, PhD, FAAN, is an Associate Professor of Harvard Medical School at the Massachusetts General Hospital. Dr. Mateen is originally from Saskatchewan, Canada, where she received her medical degree (2005). She pursued adult neurology training at the Mayo Clinic in Minnesota and a Fellowship in Medical Ethics at Harvard University (2008). Her clinical and research fellowship training was at the Johns Hopkins Hospital (2012), supported by the American Brain Foundation. She completed her doctoral studies in international health epidemiology at the Johns Hopkins University (2014) as a Sommer Scholar. Dr. Mateen is principal investigator of the Bhutan and Guinea Epilepsy Projects, a multi-country study of a smartphone-based electroencephalogram (EEG) for people with epilepsy, and the MAMBO (Measuring Ambulation, Motor, and Behavioral Outcomes) study, a phase II clinical trial of repurposing fluoxetine for post-stroke recovery in Tanzania. Her work includes collaborations throughout Africa and Asia, as well as vulnerable populations such as refugees. Dr. Mateen was the Chair of the American Academy of Neurology's Global Health Section and Ethics Section and is past chair of the International Outreach Committee of the American Neurological Association and Resident and Fellow Section Editorial Board member of Neurology. She has worked with the UN High Commissioner for Refugees, World Health Organization, Polio Eradication Initiative in Switzerland and India, and several NGOs across countries of various income levels. To date, she has published >180 academic manuscripts to advance neurological disease research and clinical care, predominantly in resource-limited settings. She directs Global Health in the Department of Neurology at the Massachusetts General Hospital and leads the Global & Humanitarian Health certificate program for the Mass General Brigham Neurology Residency. Her U.S.-based clinical practice is focused on multiple sclerosis and neuromyelitis optica.